trending Market Intelligence /marketintelligence/en/news-insights/trending/vud7daiqnibxljqbnz6sgg2 content esgSubNav
In This List

Arix Bioscience CEO transitioning to chief investment officer

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022

Blog

Insight Weekly: CEO pay jumps; yield curve inversion deepens; wind giants lift turbine prices


Arix Bioscience CEO transitioning to chief investment officer

Arix Bioscience PLC said CEO Joe Anderson will become the chief investment officer.

The company added that Anderson will also step down from the board, effective Sept. 4.

Executive Chairman Jonathan Peacock will assume corporate and operating responsibilities and will work with the board to recruit a new CEO.

London-based Arix is an investment company that invests in medical innovation comprising healthcare and the life sciences.